ASX/EBO (ASX/EBO)

Australian Securities Exchange: ASX/EBO · AUD

A$16.1

-0.04 (-0.3%)· Recorded snapshot

Market cap	3.3B
Revenue (ttm)	13.5B
Net income (ttm)	225.2M
EPS (ttm)	A$1.06
P/E (trailing)	15.2x
P/E (forward)	13.4x
Dividend	A$1.03 (6.38%)
Volume	73,652
Beta	0.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.5B
Net income (ttm): 225.2M
EPS (ttm): A$1.06
P/E (trailing): 15.2x
P/E (forward): 13.4x
Market cap: 3.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E13.4

P25 n/aP50 n/aP75 n/a

Trailing P/E15.2

P25 n/aP50 n/aP75 n/a

ROE8.3

P25 n/aP50 n/aP75 n/a

ROIC6.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/EBO indicators

Market & fundamental data

Available fields

250

Groups with data

Currency

AUD

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	New Zealand
Country code	AU
Earnings date	2026-11-24
Employees	5,718
Employees change	-52
Employees growth	-0.9%
Enterprise value	AUD 4.9B
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1922
Industry	Medical Distribution
Is primary listing	No
ISIN number	NZEBOE0001S6
Last earnings date	2026-08-19
Last refreshed	2026-10-29
Market cap	AUD 3.3B
Next earnings date	2026-11-24
Price	AUD 16.09
Price currency	AUD
Sector	Healthcare
SIC code	5047
Stock price date	2026-10-29
Symbol	asx/EBO
Website	https://www.ebosgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	24.64x
Average P/E ratio (3Y)	23.74x
Average P/E ratio (5Y)	27.12x
Earnings yield	6.6%
EV/Earnings	21.66x
EV/EBIT	12.84x
EV/EBITDA	8.95x
EV/FCF	22.42x
EV/Sales	0.37x
FCF / EV yield	4.46%
FCF yield	6.56%
Forward P/E	13.36x
Graham number	17.95449
Graham upside	11.59%
Lynch fair value	AUD 5.46
Lynch upside	-66.07%
P/(FCF - SBC) ratio	14.88x
P/(OCF - SBC) ratio	9.36x
P/B ratio	1.23x
P/E ratio	15.16x
P/FCF ratio	15.25x
P/OCF ratio	9.51x
P/S ratio	0.25x
Price/EBITDA ratio	7.12x
Sector forward P/E	33.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.8%
EBITDA margin	3.46%
Effective tax rate	24.45%
FCF margin	1.61%
Gross margin	12.93%
Operating margin	2.8%
Pretax margin	2.22%
Profit margin	1.67%
Profit per employee	AUD 41,981
Profitable quarters	42
Profitable years	23
Revenue per employee	AUD 2.5M
ROA	3.13%
ROA (5Y)	3.95%
ROCE	7.67%
ROE	8.33%
ROE (5Y)	10.29%
ROIC	6.57%
ROIC (5Y)	8.38%
SBC / revenue	-0.04%
Tax / revenue	0.54%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	0.09%
EPS growth (Q)	-7.15%
EPS growth (QoQ)	-20.18%
EPS growth 10Y	3.1%
EPS growth 3Y	-6.37%
EPS growth 5Y	-0.73%
EPS growth years	0
FCF growth	-25.84%
FCF growth (Q)	46.72%
FCF growth 3Y	-9.89%
FCF growth 5Y	-0.33%
Gross profit growth	6.48%
Gross profit growth (Q)	4.45%
Gross profit growth 3Y	4.05%
Gross profit growth 5Y	12.11%
Net income growth	4.67%
Net income growth (Q)	-4.09%
Net income growth (QoQ)	-19.58%
Net income growth 3Y	-3.85%
Net income growth 5Y	3.98%
Net income growth years	1
OCF growth	-16.63%
OCF growth (Q)	32.22%
OCF growth (QoQ)	549.15%
OCF growth 10Y	4.99%
OCF growth 3Y	-3.76%
OCF growth 5Y	3.18%
Operating income growth	-4.16%
Operating income growth (Q)	-1.57%
Operating income growth 3Y	-5.31%
Operating income growth 5Y	5.62%
Revenue growth	9.94%
Revenue growth (Q)	7.07%
Revenue growth (QoQ)	-0.72%
Revenue growth 10Y	7.09%
Revenue growth 3Y	3.29%
Revenue growth 5Y	7.94%
Revenue growth quarters	2
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -131.4M
Depreciation and amortization	AUD 88.3M
EBIT	AUD 378M
EBITDA	AUD 466.3M
EPS	AUD 1.06
Financing cash flow	AUD -12.3M
Free cash flow	AUD 217.6M
Free cash flow minus SBC	AUD 223.1M
Gross profit	AUD 1.7B
Income taxes	AUD 73.2M
Investing cash flow	AUD -271.9M
Net borrowing	AUD 111.4M
Net cash flow	AUD 54.8M
Net income	AUD 225.2M
Operating cash flow minus SBC	AUD 354.4M
Operating income	AUD 378M
Revenue	AUD 13.5B
Stock-based compensation	AUD -5.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.63
Book value per share	AUD 13.28
Debt / EBITDA	3.46
Debt / equity	0.7
Debt / FCF	8.71
Goodwill	AUD 2.3B
Interest coverage	3.03
Long-term assets	AUD 4.5B
Long-term liabilities	AUD 2.2B
Net cash (debt)	AUD -1.6B
Net cash / market cap	-49.51%
Net debt / EBITDA	3.52
Net debt / equity	0.61
Net debt / FCF	7.55
Piotroski F-Score	6
Property, plant and equipment	AUD 1.1B
Shareholders' equity	AUD 2.7B
Tangible book value	AUD -192M
Tangible book value per share	AUD -0.93
Total assets	AUD 7.8B
Total cash	AUD 252.5M
Total debt	AUD 1.9B
Total liabilities	AUD 5.1B
WACC	5.09%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.78
Current assets	AUD 3.4B
Current liabilities	AUD 2.9B
Current ratio	1.16
Inventory turnover	8.58
Net working capital	AUD 365.7M
Quick ratio	0.64
Working capital	AUD 466.9M
Working capital turnover	30.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.61%
Dividend growth	-7.75%
Dividend growth (10Y)	6.15%
Dividend growth (3Y)	-1.05%
Dividend growth (5Y)	3.22%
Dividend growth years	0
Dividend payment date	2026-09-18
Dividend payment years	13
Dividend payout frequency	Semi-Annual
Dividend per share	AUD 1.03
Dividend yield	6.38%
Ex-dividend date	2026-08-27
Last dividend	AUD 0.53
Payout ratio	56.91%
Shareholder yield	1.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	0.56%
10Y return CAGR	3.62%
10Y total return	42.72%
150-day SMA	AUD 17.24
1D price change	-0.25%
1M price change	3.47%
1M total return	3.47%
1W price change	-6.24%
1W total return	-6.24%
1Y price change	-34.62%
1Y return CAGR	-30.96%
1Y total return	-30.94%
20-day SMA	AUD 16.06
200-day SMA	AUD 18.01
3M price change	-10.46%
3M total return	-7.81%
3Y price change	-49.35%
3Y return CAGR	-16.9%
3Y total return	-42.63%
50-day SMA	AUD 16.42
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 26.00
52-week high date	2025-11-17
52-week low	AUD 14.87
52-week low date	2026-10-05
5Y price change	-51.68%
5Y return CAGR	-10.38%
5Y total return	-42.19%
6M price change	-6.94%
6M total return	-4.19%
All-time high	AUD 45.77
All-time high date	2023-01-17
All-time low	AUD 8.00
All-time low date	2014-10-17
Average true range (ATR)	AUD 0.46
Average volume	96.2K
Beta (5Y)	0.17
Change from 52-week high	-38.12%
Change from 52-week low	8.2%
Change from all-time high	-64.85%
Change from all-time low	101.13%
Change from open	-0.98%
Day's gap	0.74%
Dollar volume	AUD 1.2M
High price	AUD 16.25
Low price	AUD 15.92
Monthly RSI	27.7
Open price	AUD 16.25
Position in 52-week range	51.52%
Previous close	AUD 16.13
Price vs 150-day SMA	-6.66%
Price vs 20-day SMA	0.19%
Price vs 200-day SMA	-10.67%
Price vs 50-day SMA	-2.03%
Relative volume	0.77
RSI	47.04
Sharpe ratio	-1.41
Sharpe ratio (3Y)	-0.71
Sharpe ratio (5Y)	-0.42
Sortino ratio	-1.77
Sortino ratio (3Y)	-0.74
Sortino ratio (5Y)	-0.37
Volume	73.7K
Weekly RSI	40.45
YTD price change	-31.94%
YTD total return	-28.11%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	196.9M
Shares change (QoQ)	0.81%
Shares change (YoY)	4.61%
Shares held by insiders	0.07%
Shares held by institutions	32.83%

Deeper analysis on ASX/EBO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/EBO report

Is a complete ASX/EBO research report available?

No complete published report is available for asx/EBO (ASX/EBO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/EBO (ASX/EBO)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/EBO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/EBO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/EBO

Frequently asked questions